Based on data from the past 90 days ending January 10, 2026, Artiva Biotherapeutics's three largest insider shareholders are TenPercentOwner Corp. Gc (4.57Mn shares), TenPercentOwner Global Strategic Fund Iii, L.P. Venbio (1.94Mn shares), Director Yong-Jun Huh (1.26Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Corp. Gc | 4,567,412 | 22 Jul, 2024 | |
| Global Strategic Fund Iii, L.P. Venbio | 1,936,637 | 22 Jul, 2024 | |
| Yong-Jun Huh | 1,260,512 | 22 Jul, 2024 | |
| Fred Aslan | President And Ceo | 1,209,948 | 15 Dec, 2025 |
| Partners Vi, Llc 5am | 1,182,054 | 24 Jul, 2024 | |
| Capital Management, L.P. Ra | 826,832 | 24 Jul, 2024 | |
| Jennifer Bush | Coo And Clo And Secy And Compliance Off | 232,925 | 12 Dec, 2025 |
| Biomedical Innovation Master Investors (Cayman) I L.P. Wellington | 194,108 | 22 Jul, 2024 | |
| Christopher Horan | Chief Tech Operations Officer | 185,339 | 12 Dec, 2025 |
| Heather Raymon | Svp And Research And Development | 106,844 | 12 Dec, 2025 |
| Neha Krishnamohan | Chief Financial Officer | 99,356 | 17 Nov, 2025 |
| Thorsten Graef | Chief Medical Officer | 80,000 | 28 Feb, 2025 |
| Subhashis Banerjee | Chief Medical Officer | 50,000 | 25 Apr, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Dec, 2025 | Fred Aslan | Common Stock | D | 3,187 | $6.00 | 1,209,948 | D | S |
| 12 Dec, 2025 | Jennifer Bush | Common Stock | A | 84,877 | $0.00 | 232,925 | D | A |
| 12 Dec, 2025 | Christopher Horan | Common Stock | A | 107,156 | $0.00 | 185,339 | D | A |
| 12 Dec, 2025 | Fred Aslan | Common Stock | A | 869,136 | $0.00 | 1,213,135 | D | A |
| 12 Dec, 2025 | Heather Raymon | Common Stock | A | 67,253 | $0.00 | 106,844 | D | A |
| 17 Nov, 2025 | Fred Aslan | Common Stock | D | 6,375 | $3.38 | 343,999 | D | S |
| 15 Nov, 2025 | Jennifer Bush | Common Stock | D | 3,055 | $3.25 | 148,048 | D | F |
| 15 Nov, 2025 | Christopher Horan | Common Stock | D | 1,899 | $3.25 | 78,183 | D | F |
| 15 Nov, 2025 | Neha Krishnamohan | Common Stock | D | 3,490 | $3.25 | 99,356 | D | F |
| 15 Nov, 2025 | Fred Aslan | Common Stock | D | 6,347 | $3.25 | 350,374 | D | F |
| 15 Nov, 2025 | Heather Raymon | Common Stock | D | 1,375 | $3.25 | 39,591 | D | F |
| 17 Oct, 2025 | Fred Aslan | Common Stock | D | 25,500 | $6.00 | 356,721 | D | S |
| 08 Apr, 2025 | Subhashis Banerjee | Common Stock | A | 50,000 | $0.00 | 50,000 | D | A |
| 08 Apr, 2025 | Subhashis Banerjee | - | - | 50,000 | D | |||
| 05 Mar, 2025 | Fred Aslan | Common Stock | A | 200,000 | $0.00 | 416,665 | D | A |
| 26 Feb, 2025 | Thorsten Graef | - | - | 80,000 | D | |||
| 26 Feb, 2025 | Thorsten Graef | Common Stock | A | 60,000 | $0.00 | 80,000 | D | A |
| 26 Feb, 2025 | Jennifer Bush | Common Stock | A | 86,650 | $0.00 | 159,449 | D | A |
| 26 Feb, 2025 | Christopher Horan | Common Stock | A | 60,000 | $0.00 | 85,000 | D | A |
| 26 Feb, 2025 | Neha Krishnamohan | Common Stock | A | 60,000 | $0.00 | 110,000 | D | A |